Samuel Klein Selected Research

Adiponectin

4/2024	Cardiometabolic characteristics of people with metabolically healthy and unhealthy obesity.
1/2023	Heterogeneity in the effect of marked weight loss on metabolic function in women with obesity.
1/2021	Importance of Adipose Tissue NAD+ Biology in Regulating Metabolic Flexibility.
1/2017	Alterations in 3-Hydroxyisobutyrate and FGF21 Metabolism Are Associated With Protein Ingestion-Induced Insulin Resistance.
8/2012	Relationship between Changes in Plasma Adiponectin Concentration and Insulin Sensitivity after Niacin Therapy.
11/2011	Portal vein and systemic adiponectin concentrations are closely linked with hepatic glucose and lipoprotein kinetics in extremely obese subjects.
3/2010	Effects of long-term calorie restriction and endurance exercise on glucose tolerance, insulin action, and adipokine production.
3/2007	Effect of marked weight loss on adiponectin gene expression and plasma concentrations.
6/2004	Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Samuel Klein Research Topics

Disease

92	Insulin Resistance 04/2024 - 05/2004
91	Obesity 04/2024 - 04/2002
73	Weight Loss (Weight Reduction) 01/2023 - 06/2002
29	Type 2 Diabetes Mellitus (MODY) 12/2023 - 02/2002
22	Non-alcoholic Fatty Liver Disease 02/2023 - 05/2006
19	Inflammation (Inflammations) 04/2024 - 05/2006
18	Body Weight (Weight, Body) 12/2023 - 06/2002
16	Overweight 01/2024 - 06/2002
10	Hyperinsulinism (Hyperinsulinemia) 12/2022 - 02/2002
9	Glucose Intolerance 11/2023 - 08/2004
8	Hyperglycemia 01/2024 - 04/2003
7	Prediabetic State (Prediabetes) 04/2024 - 10/2019
7	Abdominal Obesity 12/2008 - 04/2002
6	Weight Gain 03/2023 - 02/2015
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 06/2002
6	Dyslipidemias (Dyslipidemia) 01/2023 - 05/2005
5	Neoplasms (Cancer) 01/2024 - 12/2006
5	Coronary Disease (Coronary Heart Disease) 05/2023 - 05/2003
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2023 - 07/2014
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2023 - 06/2008
4	Metabolic Diseases (Metabolic Disease) 11/2022 - 06/2008
4	Fibrosis (Cirrhosis) 10/2022 - 12/2020
2	Fatty Liver 11/2023 - 01/2021
2	Hypertension (High Blood Pressure) 05/2023 - 01/2023
2	Chronic Renal Insufficiency 01/2023 - 02/2012
2	Liver Diseases (Liver Disease) 01/2022 - 01/2021
2	Hypoxia (Hypoxemia) 01/2019 - 11/2012
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2011 - 10/2006

Drug/Important Bio-Agent (IBA)

82	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 02/2002
62	Insulin (Novolin)FDA Link 04/2024 - 02/2002
28	Triglycerides (Triacylglycerol)IBA 04/2024 - 02/2008
22	Fatty Acids (Saturated Fatty Acids)IBA 04/2024 - 02/2002
21	LipidsIBA 12/2023 - 06/2002
19	Proteins (Proteins, Gene)FDA Link 11/2022 - 04/2002
14	Nonesterified Fatty Acids (NEFA)IBA 01/2024 - 03/2003
13	IsotopesIBA 01/2019 - 04/2002
12	PalmitatesIBA 10/2020 - 02/2002
11	very low density lipoprotein triglycerideIBA 01/2024 - 03/2003
11	Therapeutic UsesIBA 01/2023 - 03/2011
10	VLDL LipoproteinsIBA 01/2016 - 04/2003
9	AdiponectinIBA 04/2024 - 06/2004
7	Amino Acids FDA Link 12/2023 - 04/2002
7	Branched-Chain Amino AcidsIBA 01/2023 - 08/2013
6	CarbohydratesIBA 01/2022 - 05/2009
5	HDL CholesterolIBA 05/2023 - 06/2008
5	CytokinesIBA 03/2023 - 03/2007
4	Plasminogen Activator Inhibitor 1IBA 04/2024 - 12/2020
4	Glucagon Receptors (Glucagon Receptor)IBA 11/2023 - 01/2018
4	Interleukin-6 (Interleukin 6)IBA 03/2023 - 06/2004
4	C-Reactive ProteinIBA 03/2023 - 06/2004
4	LeptinIBA 12/2022 - 05/2011
4	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2022 - 10/2012
4	Sucrose (Saccharose)IBA 10/2021 - 05/2014
4	Orlistat (Xenical)FDA Link 01/2008 - 06/2002
3	Peptides (Polypeptides)IBA 12/2023 - 07/2015
3	RNA (Ribonucleic Acid)IBA 11/2023 - 01/2021
3	volagidemabIBA 11/2023 - 01/2018
3	HDL LipoproteinsIBA 05/2023 - 12/2008
3	LDL CholesterolIBA 05/2023 - 12/2008
3	Glucagon (Glukagon)FDA Link 10/2022 - 06/2008
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2018
3	Messenger RNA (mRNA)IBA 01/2021 - 02/2016
3	Dopamine (Intropin)FDA LinkGeneric 01/2020 - 11/2013
3	Leucine (L-Leucine)FDA Link 05/2018 - 10/2006
3	Apolipoprotein B-100 (Apo B 100)IBA 11/2016 - 03/2003
3	C-PeptideIBA 07/2015 - 06/2008
3	Lipoproteins (Lipoprotein)IBA 06/2012 - 03/2003
3	Glycerol (Glycerine)FDA LinkGeneric 05/2011 - 02/2002
2	CholesterolIBA 05/2023 - 04/2016
2	lipineIBA 02/2023 - 09/2007
2	Alanine Transaminase (SGPT)IBA 11/2022 - 01/2022
2	LDL Lipoproteins (beta Lipoproteins)IBA 10/2022 - 12/2008
2	Nicotinamide MononucleotideIBA 11/2021 - 01/2021
2	gamma-Aminobutyric Acid (GABA)IBA 01/2021 - 01/2021
2	CollagenIBA 01/2021 - 05/2006
2	Oxygen (Dioxygen)IBA 12/2020 - 01/2019
2	ChemokinesIBA 12/2020 - 03/2007
2	fibroblast growth factor 21IBA 10/2017 - 01/2017
2	CalciumIBA 02/2016 - 07/2012
2	Hormones (Hormone)IBA 07/2015 - 12/2006
2	AntioxidantsIBA 09/2014 - 03/2014
2	Uric Acid (Urate)IBA 09/2014 - 03/2014
2	Bile Acids and Salts (Bile Acids)IBA 04/2013 - 08/2010
2	ginsenoside ReIBA 11/2012 - 05/2011
2	Niacin (Nicotinic Acid)FDA LinkGeneric 08/2012 - 06/2010
2	Insulin-Like Growth Factor I (IGF-1)IBA 03/2010 - 10/2008
2	AdipokinesIBA 12/2009 - 04/2007

Therapy/Procedure

37	Therapeutics 01/2024 - 02/2002
21	Gastric Bypass (Roux-en-Y Gastric Bypass) 01/2023 - 05/2006
12	Glycemic Control 10/2022 - 06/2002
9	Caloric Restriction 01/2023 - 04/2004
8	Bariatric Surgery 01/2022 - 01/2008
7	Drug Therapy (Chemotherapy) 01/2022 - 12/2004
5	Fat-Restricted Diet (Diet, Fat Restricted) 10/2019 - 11/2004
4	Carbohydrate-Restricted Diet (Low Carbohydrate Diet) 10/2019 - 05/2003
3	Aftercare (After-Treatment) 01/2024 - 08/2010
3	Gastrectomy 12/2017 - 08/2014
3	Diet Therapy (Therapy, Diet) 12/2009 - 03/2007
2	Injections 01/2021 - 03/2013
2	Lipectomy (Liposuction) 12/2008 - 06/2004